Collections:
Other Resources:
DOI: 10.1182/blood.2021014689
Paper Summary:
Title: Asciminib: new therapeutic option in chronic phase CML with treatment failure.
Author(s): Yeung, David T; Shanmuganathan, Naranie; Hughes, Timothy P
Year: 2022
DOI: 10.1182/blood.2021014689
URL: https://doi.org/10.1182/blood.2021014689
Received on: 2022-10-26
✍: FYIcenter.com
2022-10-26, ∼1117👍, 0💬
Related Topics:
Popular Posts:
Paper Summary: Title: Atlas of Hematopathology || Therapy-Related Myeloid Neoplasms Author(s): Naeim...
Paper Summary: Title: Angular Dependence of Si 3 N 4 Etching in C 4 F 6 /CH 2 F 2 /O 2 /Ar Plasmas A...
Paper Summary: Title: [Lecture Notes in Computer Science] Intelligent Agents III Agent Theories, Arc...
Paper Summary: Title: Knowledge Learning of Insurance Risks Using Dependence Models Author(s): Zhao,...
Paper Summary: DOI: 10.1016/j.susmat.2023.e0 0683Received on: 2024-04-13
